HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Wee Joo Chng Selected Research

Pronase

1/2022Fibrillary Glomerulonephritis and Monoclonal Gammopathy: Potential Diagnostic Challenges.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Wee Joo Chng Research Topics

Disease

43Neoplasms (Cancer)
01/2022 - 07/2010
40Multiple Myeloma
03/2022 - 04/2005
8Lymphoma (Lymphomas)
01/2022 - 03/2012
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2022 - 01/2011
6Neoplasm Metastasis (Metastasis)
10/2020 - 07/2010
4Carcinogenesis
01/2019 - 02/2010
4Infections
09/2018 - 11/2012
3T-Cell Lymphoma (Lymphoma, T Cell)
01/2022 - 01/2020
3Monoclonal Gammopathy of Undetermined Significance
01/2022 - 02/2008
3Paraproteinemias (Monoclonal Gammopathy)
01/2022 - 02/2008
3Hypoxia (Hypoxemia)
01/2021 - 01/2016
3Leukemia
01/2021 - 11/2016
3Hematologic Neoplasms (Hematological Malignancy)
01/2021 - 01/2018
3Residual Neoplasm
01/2021 - 01/2017
3BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017 - 03/2012
2COVID-19
06/2022 - 10/2020
2B-Cell Lymphoma (Lymphoma, B Cell)
01/2022 - 12/2016
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2021 - 01/2014
2Diarrhea
01/2020 - 09/2015
2Febrile Neutropenia
09/2018 - 11/2012
2Neutropenia
01/2018 - 09/2015
2Necrosis
01/2018 - 04/2014
2Breast Neoplasms (Breast Cancer)
01/2017 - 01/2016
1Communicable Diseases (Infectious Diseases)
06/2022
1Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2022
1Amyloidosis
01/2022
1Hepatocellular Carcinoma (Hepatoma)
01/2022
1Colonic Neoplasms (Colon Cancer)
01/2022
1Chromosome Aberrations (Chromosome Abnormalities)
01/2022
1Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
12/2021
1Ischemia
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2021
1Osteonecrosis (Kienbock's Disease)
01/2020

Drug/Important Bio-Agent (IBA)

12Proteins (Proteins, Gene)FDA Link
01/2021 - 07/2010
10Pharmaceutical PreparationsIBA
06/2022 - 02/2013
7Bortezomib (Velcade)FDA Link
01/2020 - 09/2013
6Chimeric Antigen ReceptorsIBA
01/2022 - 01/2018
5Oncogene Proteins (Oncogene Protein)IBA
11/2021 - 02/2012
5DNA (Deoxyribonucleic Acid)IBA
01/2020 - 09/2005
5Phosphoric Monoester Hydrolases (Phosphatases)IBA
01/2019 - 07/2010
4Dexamethasone (Maxidex)FDA LinkGeneric
03/2022 - 09/2015
4RNA (Ribonucleic Acid)IBA
01/2022 - 01/2018
4Biological ProductsIBA
01/2022 - 02/2008
4ChromatinIBA
01/2022 - 12/2016
4Biomarkers (Surrogate Marker)IBA
10/2020 - 07/2013
4MicroRNAs (MicroRNA)IBA
11/2016 - 10/2011
3Lenalidomide (CC 5013)FDA Link
03/2022 - 09/2015
3daratumumabIBA
03/2022 - 01/2021
3Zoledronic Acid (Zometa)FDA Link
01/2022 - 01/2018
3Immunoglobulins (Immunoglobulin)IBA
01/2022 - 01/2014
3Interleukin-6 (Interleukin 6)IBA
01/2020 - 12/2012
3Proteasome InhibitorsIBA
10/2019 - 09/2015
3CytokinesIBA
01/2018 - 12/2012
3Tyrosine Kinase InhibitorsIBA
09/2013 - 03/2012
2ParaproteinsIBA
01/2022 - 01/2018
2T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2022 - 01/2015
2Histones (Histone)IBA
01/2022 - 01/2017
2bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA
01/2022 - 01/2022
2AntibodiesIBA
01/2021 - 02/2012
2HydrolasesIBA
10/2020 - 01/2011
2AntigensIBA
10/2020 - 01/2019
2Cisplatin (Platino)FDA LinkGeneric
01/2020 - 07/2015
2Histone MethyltransferasesIBA
01/2020 - 08/2012
2Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2019 - 12/2018
2carfilzomibIBA
10/2019 - 01/2019
2Drug CombinationsIBA
01/2019 - 01/2018
2Carbapenems (Carbapenem Antibiotics)IBA
09/2018 - 11/2012
2VS-5584IBA
11/2017 - 02/2013
2Telomerase (Telomerase Reverse Transcriptase)IBA
12/2016 - 12/2012
2Messenger RNA (mRNA)IBA
11/2016 - 02/2008
2Anti-Bacterial Agents (Antibiotics)IBA
06/2014 - 11/2012
2ErbB Receptors (EGF Receptor)IBA
02/2013 - 03/2012
2Phosphotransferases (Kinase)IBA
02/2013 - 03/2012
1ibrutinibIBA
01/2022
1PronaseIBA
01/2022
1Histone ChaperonesIBA
01/2022
1Lysine (L-Lysine)FDA Link
01/2022
1ZAP-70 Protein-Tyrosine Kinase (ZAP 70 Protein Tyrosine Kinase)IBA
01/2022
1B-Cell Maturation AntigenIBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1ParaffinIBA
01/2022
1Immunoglobulin G (IgG)IBA
01/2022
13' Untranslated Regions (3' UTR)IBA
01/2022
1Histone-Lysine N-MethyltransferaseIBA
01/2022
1Methotrexate (Mexate)FDA LinkGeneric
12/2021
16-methyladenineIBA
11/2021
1Tumor Suppressor Protein p14ARF (p14ARF)IBA
05/2021
1Thyroid Hormone Receptors (Thyroid Hormone Receptor)IBA
05/2021
1Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA
05/2021
15-methoxy-methylindoleacetic acid (DBI)IBA
03/2021
1Asparaginase (Elspar)FDA Link
01/2021
1Oxygen (Dioxygen)IBA
01/2021
1ras ProteinsIBA
01/2021
1IsotopesIBA
10/2020

Therapy/Procedure

28Therapeutics
06/2022 - 04/2005
6Drug Therapy (Chemotherapy)
01/2021 - 08/2012
5Immunotherapy
01/2022 - 01/2014
1Cell- and Tissue-Based Therapy (Cell Therapy)
01/2022
1Intravenous Injections
01/2022
1Artificial Respiration (Mechanical Ventilation)
10/2020